JPMorgan increases its shareholding in GenScript Biotech (01548.HK) by approximately 16.7171 million shares at approximately HK$32.02 per share.

Zhitong Finance APP has learned that the latest information from the Hong Kong Stock Exchange shows that on September 11, JPMorgan Chase increased its holdings in GenScript Biotech (01548.HK) by 16.717077 million shares at HK$32.0248 per share, for a total amount of approximately HK$535 million. After the increase, its latest shareholding was approximately 165 million shares, with its latest shareholding ratio at 7.48%.